Literature DB >> 17067532

[Angiosarcoma in chronic lymphedema].

Alfonso Rodríguez-Bujaldón1, Maria Carmen Vázquez-Bayo, Manolo Galán-Gutiérrez, Rafael Jiménez-Puya, Antonio Vélez García-Nieto, José Carlos Moreno-Giménez, Alfredo Vidal-Jiménez, Elisa Barroso-Casamitjana.   

Abstract

Angiosarcoma that develops on a limb with chronic lymphedema is called Stewart-Treves syndrome. This typically appears as a complication of a long course lymphedema located on the arm, after mastectomy and/or radiotherapy due to breast cancer. There are cases of Stewart-Treves syndrome in chronic lymphedema in the upper limb contralateral to the breast treated for cancer and in chronic lymphedema of the leg. We present two cases of this syndrome. The first corresponds to a typical syndrome of Stewart-Treves in an 83-year-old woman who was diagnosed of angiosarcoma in a chronic lymphedema territory secondary to mastectomy and radiotherapy due to breast cancer. The second case is much rarer, since it is a case of diffuse angiosarcoma of the leg in a 42-year-old man with a history of lymphedema. Due to the aggressive nature of this syndrome, knowledge and research on its treatment are necessary.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17067532     DOI: 10.1016/s0001-7310(06)73456-1

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  3 in total

1.  Unsuspected Stewart-Treves syndrome clinically mimicked by apparent bullous erysipelas and a systematic review of dermatological presentations of the classical Stewart-Treves syndrome.

Authors:  René Aloisio da Costa Vieira; Igor de Araujo Silva; Idam de Oliveira-Junior; Mauricio Eiji de Almeida Santos Yamashita; Sandra Regina Morini da Silva
Journal:  Cancer Rep (Hoboken)       Date:  2018-10-25

2.  Acquired lymphangiectasis following surgery and radiotherapy of breast cancer.

Authors:  Angoori Gnaneshwar Rao
Journal:  Indian J Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.494

3.  Author's Reply.

Authors:  Angoori Gnaneshwar Rao
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.